Capital International Investors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272M | Sell |
|
|||||
|
2025
Q1 | $207M | Sell |
|
|||||
|
2024
Q4 | $344M | Buy |
|
|||||
|
2024
Q3 | $372M | Buy |
|
|||||
|
2024
Q2 | $425M | Buy |
|
|||||
|
2024
Q1 | $534M | Buy |
|
|||||
|
2023
Q4 | $384M | Buy |
|
|||||
|
2023
Q3 | $276M | Buy |
|
|||||
|
2023
Q2 | $341M | Buy |
|
|||||
|
2023
Q1 | $272M | Buy |
|
|||||
|
2022
Q4 | $218M | Buy |
|
|||||
|
2022
Q3 | $349M | Buy |
|
|||||
|
2022
Q2 | $283M | Buy |
|
|||||
|
2022
Q1 | $226M | Buy |
|
|||||
|
2021
Q4 | $272M | Sell |
|
|||||
|
2021
Q3 | $468M | Sell |
|
|||||
|
2021
Q2 | $743M | Sell |
|
|||||
|
2021
Q1 | $593M | Sell |
|
|||||
|
2020
Q4 | $1.14B | Buy |
|
|||||
|
2020
Q3 | $618M | Buy |
|
|||||
|
2020
Q2 | $40.6M | Hold |
|
|||||
|
2020
Q1 | $23.5M | Buy |
|
|||||
|
2019
Q4 | $22.8M | Buy |
|
|||||
|
2019
Q3 | $5.66M | Hold |
|
|||||
|
2019
Q2 | $6.5M | Hold |
|
|||||
|
2019
Q1 | $4.93M | Hold |
|
|||||
|
2018
Q4 | $3.94M | Hold |
|
|||||
|
2018
Q3 | $6.12M | Buy |
|